Drug intelligence / Profile preview

VX-708 + itraconazole

Development stage
Unknown
Lead developer
Vertex
Modality
Small Molecules
Administration
Oral
01

Overview

VX-708 + itraconazole is a combination of two drugs: VX-708, a small molecule inhibitor developed by Vertex Pharmaceuticals that blocks voltage-gated sodium channels (VGSCs), and itraconazole, an antifungal agent commonly known for potentiating drug-drug interactions via CYP3A4 inhibition. VX-708 is under investigation for nervous system diseases, particularly pain, with phase 1 clinical trials evaluating its safety and pharmacokinetics in healthy participants. The combination with itraconazole is likely employed to study potential pharmacokinetic interactions, as itraconazole is a strong CYP3A4 inhibitor and may alter the metabolism of VX-708, but there are no approvals or specific disease indications reported for this exact combination.

Other names
VX 708VX708VX-708
02

Targets

CYP3A4 (Cytochrome P450 3A4)CYP51A1 (Sterol 14α-demethylase)

Beyond the preview

Go deeper on VX-708 + itraconazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on VX-708 + itraconazole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call